Ascorbate conversion to oxalate in alkaline milieu and Proteus mirabilis culture
- PMID: 11156698
Ascorbate conversion to oxalate in alkaline milieu and Proteus mirabilis culture
Abstract
Background and purpose: Ascorbate breakdown reportedly accounts for 30% to 55% of urinary oxalate excreted. Three potential degradation routes can be postulated: bowel, endogenous, and urinary. Because the pH of normal urine ranges from 4.5 to 8.0, the urinary oxalate concentration in the presence of ascorbate may be influenced by urinary pH and environment, so we studied ascorbate conversion to oxalate in standard buffer solution and in urine. About 10% of infection stones associated with Proteus mirabilis are reportedly composed of calcium oxalate, and their pathogenesis is not well explained. Therefore, we studied whether a pH change induced by P. mirabilis contributes to ascorbate conversion to oxalate in vitro.
Results: Oxalate production from ascorbate increased as a function of pH (7.0-10.0) and incubation time (30 minutes-24 hours) in standard and urine specimens. Two-hour exposure to pH 10 in a urinary milieu containing approximately 3 mM ascorbate converted approximately 40% of the ascorbate to oxalate, whereas 24-hour exposure to pH 8 in a urinary milieu that was approximately 3 mM ascorbate converted approximately 20% of the ascorbate to oxalate. The pH in Proteus cultures increased to 9.0 at 24 hours of culture. The ascorbate concentration in the culture medium significantly decreased at 12 hours and 24 hours, and the oxalate concentration increased significantly at 24 hours.
Conclusion: Urinary ascorbate, if present at a high concentration in association with Proteus mirabilis infection, appears to be locally degraded to oxalate, potentially leading to calcium oxalate deposition on infection stones.
Similar articles
-
Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate.Clin Chem. 1985 Oct;31(10):1703-5. Clin Chem. 1985. PMID: 3930094
-
Use of polymerase chain reaction to detect Proteus mirabilis and Ureaplasma urealyticum in urinary calculi.J Formos Med Assoc. 1999 Dec;98(12):844-50. J Formos Med Assoc. 1999. PMID: 10634025
-
Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.J Urol. 2004 Sep;172(3):958-61. doi: 10.1097/01.ju.0000136400.14728.cd. J Urol. 2004. PMID: 15311008 Clinical Trial.
-
[Nephrolithiasis in patients with intestinal diseases].G Ital Nefrol. 2008 Jan-Feb;25(1):42-8. G Ital Nefrol. 2008. PMID: 18264917 Review. Italian.
-
Oxalate and urinary stones.World J Surg. 2000 Oct;24(10):1154-9. doi: 10.1007/s002680010193. World J Surg. 2000. PMID: 11071450 Review.
Cited by 1 article
-
Vitamin B6 deficiency augments endogenous oxalogenesis after intravenous L-hydroxyproline loading in rats.Urol Res. 2007 Feb;35(1):15-21. doi: 10.1007/s00240-006-0076-y. Epub 2007 Jan 3. Urol Res. 2007. PMID: 17200872
MeSH terms
Substances
LinkOut - more resources
Medical